Trial intelligence / Profile preview

Effect of Bepreve on Tear Film in Allergic Conjunctivitis

NCT01346371Phase 4Completed

Sponsor
Minnesota Eye Consultants
Start
May 2011
Primary completion
Aug 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bepotastine in allergic conjunctivitis (AC), sponsored by Minnesota Eye Consultants. Started May 2011; status: completed.

02

Drugs

bepotastine
03

Conditions

allergic conjunctivitis (AC)

Beyond the preview

Go deeper on NCT01346371.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01346371.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call